Diverticulitis Disease Market Trends and Insights: Global Forecast to 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the diverticulitis disease market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Diverticulitis Disease Market size between 2026 and 2035?

The diverticulitis disease market has observed robust expansion in recent years. It is anticipated to rise from $2.02 billion in 2025 to $2.21 billion in 2026, with a compound annual growth rate (CAGR) of 9.0%. This historical expansion is attributable to several factors, including an increasing aging population, diets deficient in fiber, constraints in early diagnosis, treatment models predominantly based in hospitals, and a rise in the prevalence of gastrointestinal disorders.

The diverticulitis disease market is projected to experience robust expansion over the coming years, with its valuation anticipated to reach $3.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This projected increase during the forecast period stems from factors such as heightened awareness of preventive digestive health, enhanced access to imaging services, the broader availability of outpatient care, a decline in surgical intervention rates, and an increased emphasis on lifestyle adjustments. Significant developments expected within this period encompass a rise in the diagnosis of uncomplicated diverticulitis, a growing inclination towards conservative and outpatient treatment approaches, the expanding application of imaging-based diagnostic methods, the broadening scope of antibiotic and supportive care, and greater understanding of dietary and lifestyle management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

Which Drivers Are Impacting Market Performance In The Diverticulitis Disease Market?

The increasing incidence of smoking addiction is anticipated to boost the expansion of the diverticulitis disease market in the future. This addiction denotes an uncontrollable reliance on nicotine products like cigarettes, vapes, and other tobacco articles. The rise in smoking addiction can be attributed to assertive marketing campaigns, enhanced social acceptance, stress factors, and the wider availability of e-cigarettes and vaping tools. The market for diverticulitis treatment is bolstered by this trend, as smoking impairs colonic blood flow and intensifies both the likelihood and seriousness of diverticular disease, consequently increasing the demand for diagnostic and therapeutic interventions. For example, a study by the Switzerland-based non-profit European Respiratory Society’s (ERS) in October 2024 highlighted a substantial increase in smoking rates among young individuals, showing 22.5% of respondents smoked in 2022, which rose to 40.1% by 2024. Consequently, the growing prevalence of smoking addiction will fuel the expansion of the diverticulitis disease market.

Which Segments Are Contributing To The Growth Of The Diverticulitis Disease Market?

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids

4) By End-User: Specialty Centers, Hospitals, Research Centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

What Upcoming Trends Are Likely To Define The Future Path Of The Diverticulitis Disease Market?

Leading companies in the diverticulitis disease market are engaged in developing and securing approval for innovative drugs to maintain their competitive edge. The progression of drug development holds the potential to introduce more efficacious treatments for diverticulitis, thereby lowering the likelihood of complications and enhancing patient outcomes. For instance, in April 2023, the United States Food and Drug Administration, a US-based federal organization, authorized Seres’ microbiota drug for recurrent gut infections. This medication is specifically designed to manage recurring gut infections and prevent the reoccurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The endorsement of Vowst was grounded in a clinical trial that included 346 patients suffering from recurrent CDI. The findings from this trial indicated that patients who received Vowst were significantly less likely to experience a return of the infection compared to the placebo group. The drug is administered orally and leverages microbiota containing Firmicutes spores, which are known for contributing to a healthy microbiome capable of resisting C. diff. colonization.

Who Are The Prominent Global Companies Shaping The Diverticulitis Disease Market Landscape?

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Diverticulitis Disease Market?

North America was the largest region in the diverticulitis disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diverticulitis disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Diverticulitis Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp

Browse Through More Reports Similar to the Global Diverticulitis Disease Market 2026, By The Business Research Company

Ulcerative Colitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Intestinal Pseudo Obstruction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Intestinal Pseudo Obstruction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795